IP Library Granted Patent US 12,337,139
Granted Patent B2
US 12,337,139 · App. 17/109,434 · Granted Jun 24, 2025

Medical devices for agent delivery and related methods of use

Inventors: Andrew Pic (Northboro, MA); Collin Murray (Maynard, MA); Laurie A. Lehtinen (Boylston, MA)
Assignee: Boston Scientific Scimed, Inc.
A61M5/155A61M5/16804A61M39/24A61M2039/248A61M2202/064A61M2205/75A61M2210/1042
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,337,139
App. No.
17/109,434
Granted
Jun 24, 2025
Kind
B2
Abstract

A device may be configured to deliver an agent to a target tissue via a pressurized fluid and the device may include a catheter including a lumen; an enclosure configured to store the agent, receive the pressurized fluid, and release a combination of the pressurized fluid and the agent; and a valve downstream of the enclosure to receive the combination of the pressurized fluid and the agent from the enclosure. The valve may have a first configuration preventing a flow of the combination through the lumen and a second configuration permitting the flow of the combination through the lumen.

Claims (46)

1. A device configured to deliver an agent to a target tissue via a pressurized fluid, the device comprising:

a catheter including a lumen;

an enclosure configured to store an agent, receive a pressurized fluid, and release a combination of the pressurized fluid and the agent; and

a valve defining a chamber positioned downstream of the enclosure to receive the combination of the pressurized fluid and the agent from the enclosure, the valve having a plunger and a rod that are configured to translate relative to the chamber between:

a first configuration in which the plunger is moved into contact with an internal surface of the chamber, thereby preventing a flow of the combination through the lumen such that the agent received within the valve from the enclosure is collected inside the chamber of the valve; and

a second configuration in which the plunger is moved out of contact with the internal surface of the chamber, thereby permitting the flow of the combination through the lumen such that the agent that is collected within the chamber is released from the valve;

wherein the plunger is coupled to the rod inside the chamber, and the rod extends at least partially out of the chamber and through a slider that is slidably coupled to the chamber.

2. The device according to claim 1 , further comprising a first fluid input configured to release pressurized fluid from a pressurized fluid container into the lumen upon coupling the container to the first fluid input.

3. The device according to claim 1 , wherein the valve is within a housing, and the internal surface of the chamber is conical to define a tapered distal portion of the valve, and wherein the tapered distal portion is configured to guide the agent that is stored inside the chamber of the valve when in the first configuration outwards towards the lumen when moved towards the second configuration;

wherein the plunger includes a conical configuration that is configured to interface with the internal surface of the chamber to form a seal between the plunger and the tapered distal portion of the valve when in the first configuration; and

wherein the housing includes a handle.

4. The device according to claim 1 , wherein the agent is a powdered medicament.

5. The device according to claim 1 , wherein the chamber is fluidically connected to the lumen via an output channel;

wherein the valve includes the rod including the plunger at a distal end of the rod, wherein the rod extends through the chamber and is configured to prevent the flow to the output channel in the first configuration and to allow the flow to the output channel in the second configuration;

the slider including a slot, wherein the rod extends out of the chamber and through the slot, and wherein the slider is configured to transition the valve from the first configuration to the second configuration by movement of the slider, thereby pulling the rod relatively upwards through the slot that is formed in the slider; and

a biasing member coupled to the rod, wherein the biasing member is configured to bias the rod towards the first configuration of the valve, thereby pulling the rod relatively downwards through the slot.

6. The device according to claim 5 , wherein the slider includes a slide on which the rod rests, the slide having a first portion including a curved surface and a second portion including a planar surface, the rod is configured to slide across each of the curved surface and the planar surface of the slide in response to translating relative to the chamber between the first configuration and the second configuration.

7. The device according to claim 6 , wherein the rod includes an end positioned outside of the chamber and extending radially outward relative to an adjacent portion of the rod that is disposed inside the chamber, and wherein the end of the rod prevents the rod from moving relatively downwards through the slot of the slider when the end of the rod contacts the curved surface of the first portion of the slide.

8. The device according to claim 7 , wherein the end of the rod slidably engages the slider along the curved surface of the first portion when in the first configuration and the planar surface of the second portion when in the second configuration.

9. The device according to claim 1 , further comprising a housing including a handle, wherein the handle includes an interior portion configured to receive a pressurized fluid container.

10. A device configured to deliver an agent via a pressurized fluid, the device comprising:

a catheter including a lumen;

an enclosure configured to store the agent, receive the pressurized fluid, and release a combination of the pressurized fluid and the agent; and

a valve in fluid communication with the catheter and the enclosure, wherein the valve is configured to receive the agent from the enclosure, the valve including a plunger, a slider, and a rod coupled to each of the plunger and the slider on opposing ends of the rod, wherein the rod extends through a portion of the slider such that the rod is movable through the slider;

wherein the slider of the valve is urged towards a first configuration in which the plunger and the rod of the valve are positioned relative to the catheter to prevent a flow of the combination of the pressurized fluid and the agent outwards through the valve and into the lumen, such that the agent is maintained inside the valve, and

wherein the slider of the valve is movable towards a second configuration in which the plunger and the rod of the valve are positioned relative to the catheter to permit the flow of the combination of the pressurized fluid and the agent out through the valve and into the lumen in response to counteracting a force urging the valve towards the first configuration.

11. The device according to claim 10 , wherein the valve includes a chamber, wherein the rod and the plunger are disposed inside the chamber such that the rod and the plunger are configured to translate relative to the chamber when the valve transitions between the first configuration and the second configuration.

12. The device according to claim 11 , wherein the plunger is configured to contact an internal surface of the chamber to prevent the flow of the combination of the agent and the pressurized fluid out of the chamber and into the lumen when the valve is in the first configuration; and

wherein the plunger is tapered radially outwards and the internal surface of the chamber is tapered radially inwards to (i) interface with the plunger when in contact with one another while the valve is in the first configuration and (ii) to guide the agent that is maintained inside the chamber out of the valve and into the lumen when the valve is moved towards the second configuration.

13. The device according to claim 12 , wherein the plunger is separated from the internal surface of the chamber to permit the flow of the combination out of the chamber and into the lumen when the valve is in the second configuration.

14. The device according to claim 13 , wherein the valve includes the rod having a distal end disposed inside the chamber and a proximal end disposed outside of the chamber, and the plunger is positioned at the distal end of the rod.

15. The device according to claim 14 , wherein the rod is biased to a first position such that the distal end inside the chamber with the plunger is moved into contact with the internal surface and the proximal end outside the chamber is moved into contact with a first surface of the slider, thereby urging the valve towards the first configuration.

16. The device according to claim 15 , wherein the rod is biased to a second position such that the distal end inside the chamber with the plunger is moved relatively away from the internal surface and the proximal end outside the chamber is moved into contact with a second surface of the slider, thereby moving the valve towards the second configuration.

17. The device according to claim 16 , wherein the valve includes a biasing member coupled to the rod, and wherein the biasing member is configured to bias the rod to the first position.

18. A device configured to deliver an agent, the device comprising:

a container for storing a pressurized fluid;

an enclosure for storing the agent;

a valve including a chamber for receiving a combination of the pressurized fluid from the container and the agent from the enclosure; and

a slider configured to move relative to the chamber;

a rod configured to move through the slider and relative to the chamber from a first position to a second position in response to the movement of the slider; and

a plunger configured to move relative to the chamber from the first position to the second position;

wherein, when in the first position, the plunger is urged into contact with an internal surface of the chamber to seal the combination of the pressurized fluid and the agent inside the chamber in response to the rod moving relatively downwards through the slider, thereby preventing the combination of the pressurized fluid and the agent from exiting the valve;

wherein, in the second position, the plunger is not in contact with the internal surface of the chamber such that the combination of the pressurized fluid and the agent is not sealed inside the chamber in response to the rod moving relatively upwards through the slider, thereby permitting the combination of the pressurized fluid and the agent to exit the valve.

19. The device according to claim 18 , wherein the valve includes the rod disposed inside the chamber and the plunger is positioned at an end of the rod;

wherein the rod is biased to the first position inside the chamber and moved relatively downwards through the slider with the plunger abutting against the internal surface.

20. The device according to claim 19 , wherein the rod is biased to the second position inside the chamber and moved relatively upwards through the slider with the plunger separated form the internal surface.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2020
From: PIC, ANDREW; MURRAY, COLLIN; LEHTINEN, LAURIE A.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 054690/0760 →
Continuity (2)
Provisional Application 62943060 · Dec 3, 2019
Related Publication 20210162122A1 · Jun 3, 2021
References Cited (183)
US 471854A · Howard · 1892 [cited by applicant]
US 881238A · Hasbrouck · 1908 [cited by applicant]
US 1145520A · Smith · 1915 [cited by applicant]
US 1599959A · Buheiji · 1926 [cited by applicant]
US 1732566A · McKendrick · 1929 [cited by applicant]
US 1933740A · Gompei · 1933 [cited by applicant]
US 2021587A · Agner · 1935 [cited by applicant]
US 2151418A · Bolté · 1939 [cited by applicant]
US 2185927A · Shelanski · 1940 [cited by applicant]
US 2478715A · Schmitt · 1949 [cited by applicant]
US 2623519A · Cohen · 1952 [cited by applicant]
US 3669113A · Altounyan et al. · 1972 [cited by applicant]
US 3940061A · Gimple et al. · 1976 [cited by applicant]
US 4184258A · Barrington et al. · 1980 [cited by applicant]
US 4427450A · Kostansek · 1984 [cited by applicant]
US 4457329A · Werley et al. · 1984 [cited by applicant]
US 4806167A · Raythatha · 1989 [cited by applicant]
US 5215221A · Dirksing · 1993 [cited by applicant]
US 5231983A · Matson et al. · 1993 [cited by applicant]
US 5273531A · Knoepfler · 1993 [cited by applicant]
US 5312331A · Kneopfler · 1994 [cited by applicant]
US 5312333A · Churinetz et al. · 1994 [cited by applicant]
US 5366122A · Guentert et al. · 1994 [cited by applicant]
US 5445612A · Terakura et al. · 1995 [cited by applicant]
US 5470311A · Setterstrom et al. · 1995 [cited by applicant]
US 5884621A · Matsugi et al. · 1999 [cited by applicant]
US 5951531A · Ferdman et al. · 1999 [cited by applicant]
US 6003512A · Gerde · 1999 [cited by applicant]
US 6484750B1 · Foos et al. · 2002 [cited by applicant]
US 6554022B2 · Wakeman · 2003 [cited by applicant]
US 6589087B2 · Mackal et al. · 2003 [cited by applicant]
US 6684917B2 · Zhu et al. · 2004 [cited by applicant]
US 6708712B2 · Wakeman · 2004 [cited by applicant]
US 6716190B1 · Glines et al. · 2004 [cited by applicant]
US 6799571B1 · Hughes et al. · 2004 [cited by applicant]
US 7178547B2 · Mackal · 2007 [cited by applicant]
US 7311270B2 · Kapila · 2007 [cited by applicant]
US 7334598B1 · Hollars · 2008 [cited by applicant]
US 7361300B2 · Kelly et al. · 2008 [cited by applicant]
US 7427607B2 · Suzuki · 2008 [cited by applicant]
US 7455248B2 · Kablik et al. · 2008 [cited by applicant]
US 7461649B2 · Gamard et al. · 2008 [cited by applicant]
US 7544177B2 · Gertner · 2009 [cited by applicant]
US 7563299B2 · Baptista da Costa et al. · 2009 [cited by applicant]
US 7673647B2 · Mackal · 2010 [cited by applicant]
US 7841338B2 · Dunne et al. · 2010 [cited by applicant]
US 7892205B2 · Palasis et al. · 2011 [cited by applicant]
US 7921874B2 · Tekulve et al. · 2011 [cited by applicant]
US 8037880B2 · Zhu et al. · 2011 [cited by applicant]
US 8097071B2 · Burgess et al. · 2012 [cited by applicant]
US 8118777B2 · Ducharme et al. · 2012 [cited by applicant]
US 8269058B2 · McCarthy et al. · 2012 [cited by applicant]
US 8313474B2 · Campbell et al. · 2012 [cited by applicant]
US 8360276B2 · Rogier et al. · 2013 [cited by applicant]
US 8361054B2 · Ducharme et al. · 2013 [cited by applicant]
US 8496189B2 · Lomond et al. · 2013 [cited by applicant]
US 8673065B2 · Burgess et al. · 2014 [cited by applicant]
US 8721582B2 · Ji · 2014 [cited by applicant]
US 8728032B2 · Ducharme et al. · 2014 [cited by applicant]
US 8741335B2 · McCarthy · 2014 [cited by applicant]
US 8827980B2 · Ji · 2014 [cited by applicant]
US 8910627B2 · Iwatschenko et al. · 2014 [cited by applicant]
US 8951565B2 · McCarthy · 2015 [cited by applicant]
US 9028437B2 · Ott et al. · 2015 [cited by applicant]
US 9089658B2 · Dunne et al. · 2015 [cited by applicant]
US 9101744B2 · Ducharme · 2015 [cited by applicant]
US 9107668B2 · Melsheimer et al. · 2015 [cited by applicant]
US 9132206B2 · McCarthy · 2015 [cited by applicant]
US 9204957B2 · Gregory et al. · 2015 [cited by applicant]
US 9205170B2 · Lucchesi et al. · 2015 [cited by applicant]
US 9205207B2 · Ji · 2015 [cited by applicant]
US 9205240B2 · Greenhalgh et al. · 2015 [cited by applicant]
US 9308584B2 · Burgess et al. · 2016 [cited by applicant]
US 9310812B2 · Costle et al. · 2016 [cited by applicant]
US 9375533B2 · Ducharme et al. · 2016 [cited by applicant]
US 9492646B2 · Hoogenakker et al. · 2016 [cited by applicant]
US 9517976B2 · Mackal · 2016 [cited by applicant]
US 9545490B2 · Iwatschenko et al. · 2017 [cited by applicant]
US 9555185B2 · Foster et al. · 2017 [cited by applicant]
US 9629966B2 · Ji · 2017 [cited by applicant]
US 9636470B2 · Pohlmann et al. · 2017 [cited by applicant]
US 9707359B2 · Kubo · 2017 [cited by applicant]
US 9713682B2 · Eistetter et al. · 2017 [cited by applicant]
US 9717897B2 · Rogier · 2017 [cited by applicant]
US 9821084B2 · Diegelmann et al. · 2017 [cited by applicant]
US 9839772B2 · Ducharme · 2017 [cited by applicant]
US 9839774B2 · Bonaldo · 2017 [cited by applicant]
US 9846439B2 · Carman et al. · 2017 [cited by applicant]
US 9867931B2 · Gittard · 2018 [cited by applicant]
US 9976660B2 · Stanton et al. · 2018 [cited by applicant]
US 10004690B2 · Lee et al. · 2018 [cited by applicant]
US 10010705B2 · Greenhalgh et al. · 2018 [cited by applicant]
US 10017231B2 · Fawcett, Jr. · 2018 [cited by applicant]
US 10036617B2 · Mackal · 2018 [cited by applicant]
US 10065004B2 · Eder et al. · 2018 [cited by applicant]
US 10173019B2 · Kaufmann et al. · 2019 [cited by applicant]
US 10384049B2 · Stanton et al. · 2019 [cited by applicant]
US 10463811B2 · Lee et al. · 2019 [cited by applicant]
US 10507293B2 · Goodman et al. · 2019 [cited by applicant]
US 10646706B2 · Rogier · 2020 [cited by applicant]
US 10730595B2 · Fawcett · 2020 [cited by applicant]
US 10751523B2 · Rogier · 2020 [cited by applicant]
US 10806853B2 · Gittard · 2020 [cited by applicant]
US 10850814B2 · Fawcett · 2020 [cited by applicant]
US 10994818B2 · Hernandez · 2021 [cited by applicant]
US 20030178440A1 · Wright · 2003 [cited by examiner]
US 20040107963A1 · Finlay et al. · 2004 [cited by applicant]
US 20040249359A1 · Palasis et al. · 2004 [cited by applicant]
US 20050121025A1 · Gamard et al. · 2005 [cited by applicant]
US 20050124932A1 · Foster et al. · 2005 [cited by applicant]
US 20050147656A1 · McCarthy et al. · 2005 [cited by applicant]
US 20050220721A1 · Kablik et al. · 2005 [cited by applicant]
US 20060004314A1 · McCarthy et al. · 2006 [cited by applicant]
US 20060213514A1 · Price et al. · 2006 [cited by applicant]
US 20070056586A1 · Price et al. · 2007 [cited by applicant]
US 20070066920A1 · Hopman et al. · 2007 [cited by applicant]
US 20070066924A1 · Hopman et al. · 2007 [cited by applicant]
US 20070082023A1 · Hopman et al. · 2007 [cited by applicant]
US 20070125375A1 · Finlay et al. · 2007 [cited by applicant]
US 20070151560A1 · Price et al. · 2007 [cited by applicant]
US 20070083137A1 · Hopman et al. · 2007 [cited by applicant]
US 20070199824A1 · Hoerr et al. · 2007 [cited by applicant]
US 20080021374A1 · Kawata · 2008 [cited by applicant]
US 20080287907A1 · Gregory et al. · 2008 [cited by applicant]
US 20090101144A1 · Gamard et al. · 2009 [cited by applicant]
US 20090112255A1 · Leopold et al. · 2009 [cited by applicant]
US 20090155342A1 · Diegemann et al. · 2009 [cited by applicant]
US 20090281486A1 · Ducharme · 2009 [cited by applicant]
US 20100121261A1 · Kablik et al. · 2010 [cited by applicant]
US 20100305505A1 · Ducharme et al. · 2010 [cited by applicant]
US 20110073200A1 · Overvaag et al. · 2011 [cited by applicant]
US 20110274726A1 · Guo et al. · 2011 [cited by applicant]
US 20110308516A1 · Price et al. · 2011 [cited by applicant]
US 20130110080A1 · Ducharme · 2013 [cited by examiner]
US 20140271491A1 · Gittard et al. · 2014 [cited by applicant]
US 20150094649A1 · Gittard · 2015 [cited by applicant]
US 20150125513A1 · McCarthy · 2015 [cited by applicant]
US 20150233485A1 · Cheng · 2015 [cited by examiner]
US 20160250011A1 · Sergi · 2016 [cited by applicant]
US 20160375202A1 · Goodman et al. · 2016 [cited by applicant]
US 20170106181A1 · Bonaldo et al. · 2017 [cited by applicant]
US 20170232141A1 · Surti et al. · 2017 [cited by applicant]
US 20170252479A1 · Ji et al. · 2017 [cited by applicant]
US 20170296760A1 · Lee et al. · 2017 [cited by applicant]
US 20180099088A1 · Gittard · 2018 [cited by applicant]
US 20180193574A1 · Smith · 2018 [cited by examiner]
US 20180214160A1 · Hoskins et al. · 2018 [cited by applicant]
US 20180339144A1 · Greenhalgh et al. · 2018 [cited by applicant]
US 20190134366A1 · Erez et al. · 2019 [cited by applicant]
US 20190217315A1 · Maguire et al. · 2019 [cited by applicant]
US 20190232030A1 · Pic · 2019 [cited by examiner]
US 20210024187A1 · Fawcett et al. · 2021 [cited by applicant]
US 20210069485A1 · Rogier · 2021 [cited by applicant]
CN 101401956B · 2012 [cited by applicant]
DE 60215438T2 · 2007 [cited by applicant]
EP 3052168B1 · 2019 [cited by applicant]
JP H07118305A · 1995 [cited by applicant]
WO 03013552A1 · 2003 [cited by applicant]
WO 2004066806A2 · 2004 [cited by applicant]
WO 2005062896A2 · 2005 [cited by applicant]
WO 2006071649A2 · 2006 [cited by applicant]
WO 2006088912A2 · 2006 [cited by applicant]
WO 2008033462A2 · 2008 [cited by applicant]
WO 2009061409A1 · 2009 [cited by applicant]
WO 2015050814A1 · 2015 [cited by applicant]
WO 2018157772A1 · 2018 [cited by applicant]
Bridevaux, Pierre-Olivier, et al. “Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study.” European Respiratory Journal 38.4 (2011):… [cited by applicant]
Giday, Samuel, et al. “Safety analysis of a hemostatic powder in a porcine model of acute severe gastric bleeding.” Digestive diseases and sciences 58.12 (2013): 3422-3428. [cited by applicant]
Giday, Samuel A., et al. “A long-term randomized controlled trial of a novel nanopowder hemostatic agent for control of severe upper gastrointestinal bleeding in a porcine model.” Gastrointestinal Endoscopy 69.5 (2009):… [cited by applicant]
Giday, S. A., et al. “Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.” Endoscopy 43.04 (2011): 296… [cited by applicant]
Regalia, Kristen, et al. “Hemospray in Gastrointestinal Bleeding.” Practical Gastroenterology. Endoscopy: Opening New Eyes, ser. 8, May 2014, pp. 13-24. 8. [cited by applicant]
Cook Medical. Hemospray Endoscopic Hemostat, Cook, 2014. (7 pages, in English). [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v1”, Cook Medical, 2012. [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v2”, Cook Medical, 2013. [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v3”, Cook Medical, 2014. [cited by applicant]
Aslanian, Harry R., and Loren Laine. “Hemostatic powder spray for GI bleeding.” Gastrointestinal endoscopy 77.3 (2013): 508-510. [cited by applicant]
Giday, S. A., et al. “Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.” Endoscopy 43.04 (2011): 296… [cited by applicant]
Retsch GmbH Haan. Sieve Analysis: Taking a Close Look at Quality, An Expert Guide to Particle Size Analysis. 2015. (56 pages, in English). [cited by applicant]
Micromeritics. Density Analysis, 2001. (6 pages, in English). [cited by applicant]
Micromeritics. “Application Note: Bulk and Skeletal Density Computations for the AutoPore.” May 2012. (3 pages, in English). [cited by applicant]
Arefnia, Ali, et al. “Comparative Study on the Effect of Tire-Derived Aggregate on Specific Gravity of Kaolin.” Electronic Journal of Geotechnical Engineering 18 (2013): 335-44. [cited by applicant]
Kesavan, Jana, et al. “Density Measurements of Materials Used in Aerosol Studies”. Edgewood Chemical Biological Center Aberdeen Proving Ground MD, 2000. [cited by applicant]
International Search Report and Written Opinion issued in related PCT/US2020/062845, dated Feb. 24, 2021 (English, 13 pages). [cited by applicant]